Eli Lilly CEO Cites Growth Beyond Weight Loss In Oncology, Immunology As Key To FY 2026 Outlook Raise – LLY Stock Surges To Record High In Pre-Market

Lilly raised its full-year revenue forecast to $91-92 billion, compared with its previous outlook of $85-87 billion.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)